MLchartDataset catalogue

nelfinavir mesylate

Term · Oncology and biomedicine · MLC-T-ONC-005725

  1. A drug that interferes with the ability of a virus to make copies of itself.

  2. The mesylate salt form of the antiviral agent nelfinavir. Nelfinavir selectively inhibits human immunodeficiency virus (HIV) protease, thereby preventing cleavage of the gag-pol viral polyprotein and resulting in the release of immature, noninfectious virions. In vivo, this agent exhibits broad tissue distribution compared to related agents.

Table 1. Record
IdentifierMLC-T-ONC-005725
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-005725",
  "term": "nelfinavir mesylate",
  "field": "Oncology and biomedicine",
  "definitions": [
    "A drug that interferes with the ability of a virus to make copies of itself.",
    "The mesylate salt form of the antiviral agent nelfinavir. Nelfinavir selectively inhibits human immunodeficiency virus (HIV) protease, thereby preventing cleavage of the gag-pol viral polyprotein and resulting in the release of immature, noninfectious virions. In vivo, this agent exhibits broad tissue distribution compared to related agents."
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/nelfinavir-mesylate/"
}

Record 11,679 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.